Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Hepatitis B
Human papillomavirus (HPV)
Systematic reviews (SYSVAC)
2017
Clear all
Type of publications
Systematic reviews (SYSVAC)
(11)
Topics
Available to download in languages
Regions
Americas
(1)
South-East Asia
(1)
Western Pacific
(1)
Countries
Diseases
Hepatitis B
(4)
Human papillomavirus (HPV)
(7)
Cholera
(1)
Haemophilus influenzae type B
(2)
Hepatitis A
(1)
HIV / AIDS
(1)
Influenza
(9)
Lyme disease, Borreliosis
(1)
Measles
(1)
Mumps
(1)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Rabies
(1)
Rotavirus
(4)
Rubella
(1)
Varicella
(1)
Vaccine topics
Administration
(5)
Economic aspects
(6)
Acceptance
(5)
Coverage
(9)
Efficacy/effectiveness
(14)
Safety
(7)
Target population
Adolescents
(5)
Adults
(5)
All age groups
(4)
Children
(1)
Newborn
(1)
Older adults
(1)
Parents/caregivers
(1)
Publication date
2017
(11)
2023
(2)
2021
(9)
2020
(9)
2019
(6)
2018
(7)
2016
(12)
2015
(9)
2014
(4)
2013
(5)
2012
(4)
2011
(2)
11 results found
2017
∙
Kim, K. LeClaire, A. R.
A systematic review of factors influencing human papillomavirus vaccination among immigrant parents in the United States
2017
∙
Ekwunife, O. I. O’Mahony, J. F. Gerber Grote, A. Mosch, C. Paeck, T. Lhachimi, S. K.
Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations
2017
∙
Wong, C. K. H. Liao, Q. Guo, V. Y. W. Xin, Y. Lam, C. L. K.
Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review
2017
∙
Favato, G. Easton, T. Vecchiato, R. Noikokyris, E.
Ecological validity of cost-effectiveness models of universal HPV vaccination: A systematic literature review
2017
∙
Fabrizi, F. Donato, F. M. Messa, P.
Efficacy and safety of reinforced versus standard vaccine schedule towards hepatitis B in chronic kidney disease: a systematic review and meta-analysis
2017
∙
Mulley, W. R. Le, S. T. Ives, K. E.
Primary seroresponses to double-dose compared with standard-dose hepatitis B vaccination in patients with chronic kidney disease: a systematic review and meta-analysis
2017
∙
Gervais, F. Dunton, K. Jiang, YiLing Largeron, N.
Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend
2017
∙
Setiawan, D. Oktora, M. P. Hutubessy, R. Riewpaiboon, A. Postma, M. J.
The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review
2017
∙
Van Den Ende, Caroline Marano, Cinzia Van Ahee, Ayla Bunge, Eveline M. De Moerlooze, Laurence
The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
2017
∙
Ende, C. van den Marano, C. Ahee, A. van Bunge, E. M. Moerlooze, L. de
The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register